Menu

Asia

Highly specialized global team advising clients on the full range of legal matters across Asia and the Pacific Rim

FibroGen Closes Largest Biotech IPO in 12 Years

Learn More

Johnson Controls Joint Venture Named a Deal of the Year by China Business Law Journal

Learn More
Why Cooley
  • Regularly advise Asia based clients on unique business opportunities and legal challenges across China, Japan, India, Taiwan, Korea, Vietnam, Australia and New Zealand
  • Highly specialized multi-lingual team, including multiple lawyers advising clients on a full range of formation and operational matters across Asia and the Pacific Rim region
  • Consistently ranks #1 in the global BioPharm Insight Licensing League Tables for global biotechnology and earns top recognition for Asia-Pacific pharmaceutical partnering and licensing transactions
  • Established in Shanghai since 2011
  • Built 100+ venture capital and private equity funds in China over 25 years and advised on 40+ India specific funds since 1995
  • Network of relationships with leading law, accounting and venture capital firms across the region
Read more
Group Contacts
Christina Zhang Partner-in-Charge - Shanghai
James Lu Partner, Shanghai
Patrick Loofbourrow Partner, Shanghai
Pang Lee Partner, Shanghai
Jordan Silber Partner, San Francisco
Lila Hope Partner, Palo Alto
Julie Wicklund Special Counsel, Palo Alto
ViewHide related contacts


Error

Listing Returned 0 Results.

More

Related Practices & Industries
Capital Markets Commercial Litigation Compensation & Benefits Fund Formation Healthcare & Life Sciences Regulatory Intellectual Property Public Companies Technology Transactions
ViewHide related news


Error

Listing Returned 0 Results.

More

ViewHide related events


Error

Listing Returned 0 Results.

More

Contact us

Back to top

© 2019 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.